Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2026-01-19 @ 7:39 PM
Study NCT ID:
NCT01955720
Status:
COMPLETED
Last Update Posted:
2016-02-11
First Post:
2013-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-30
First Submit QC Date:
None
Study First Post Date:
2013-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-11-13
Results First Submit QC Date:
None
Results First Post Date:
2016-02-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-13
Last Update Post Date:
2016-02-11
Last Update Post Date Type:
ESTIMATED